Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)

Market Cap	56.78B +15.1%
Revenue (ttm)	18.51B -15.1%
Net Income	1.70B -42.0%
EPS	1.07 -42.5%
Shares Out	1.59B
PE Ratio	33.36
Forward PE	27.16
Dividend	0.59 (1.73%)
Ex-Dividend Date	Oct 21, 2025

Volume	34,269,422
Average Volume	20,299,928
Open	34.15
Previous Close	34.29
Day's Range	34.11 - 35.79
52-Week Range	28.14 - 41.72
Beta	-0.13
RSI	56.75
Earnings Date	Apr 3, 2026

About SHE:002422

Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally. The company operates through Chuanning, Botai, and Other Business segments. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion sets, sterile dispensing and injection syringes, vein detained needles, nebulizer sets, and vacuum blood collection tubes; over-the-counter products; and APIs to treat cardiovascular, IPF, ED, anti-tumo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1996
• Employees: 20,127
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002422

Financial Performance

In 2025, SHE:002422's revenue was 18.51 billion, a decrease of -15.13% compared to the previous year's 21.81 billion. Earnings were 1.70 billion, a decrease of -42.03%.